Abstract

Oxidized low-density lipoprotein (oxLDL) and oxidized high-density lipoprotein (oxHDL), known as risk factors for cardiovascular disease, have been observed in plasma and atheromatous plaques. In a previous study, the content of oxidized phosphatidylcholine (oxPC) and lysophosphatidylcholine (lysoPC) species stayed constant in isolated in vivo oxLDL but increased in copper-induced oxLDL in vitro. In this study, we prepared synthetic deuterium-labeled 1-palmitoyl lysoPC and palmitoyl-glutaroyl PC (PGPC), a short chain-oxPC to elucidate the metabolic fate of oxPC and lysoPC in oxLDL in the presence of HDL. When LDL preloaded with d13-lysoPC was mixed with HDL, d13-lysoPC was recovered in both the LDL and HDL fractions equally. d13-LysoPC decreased by 50% after 4 h of incubation, while d13-PC increased in both fractions. Diacyl-PC production was abolished by an inhibitor of lecithin-cholesterol acyltransferase (LCAT). When d13-PGPC-preloaded LDL was incubated with HDL, d13-PGPC was transferred to HDL in a dose-dependent manner when both LCAT and lipoprotein-associated phospholipase A2 (Lp-PLA2) were inhibited. Lp-PLA2 in both HDL and LDL was responsible for the hydrolysis of d13-PGPC. These results suggest that short chain-oxPC and lysoPC can transfer between lipoproteins quickly and can be enzymatically converted from oxPC to lysoPC and from lysoPC to diacyl-PC in the presence of HDL.

Highlights

  • Lipoproteins modified by oxidation, including oxidized low-density lipoprotein and oxidized high-density lipoprotein, are crucial for atherosclerosis development

  • This in vivo oxidized low-density lipoprotein (oxLDL) had unique characteristics; first, its apoB-100 was modified with oxidized products, including oxidized phosphatidylcholine (oxPC); second, it coeluted with oxidized high-density lipoprotein (oxHDL) indicating that oxLDL could interact with oxHDL particles in this fraction; third, the binding of oxLDL and oxHDL was not covalent but electrostatic

  • These results suggest that the lipoprotein-associated phospholipase A2 (Lp-Phospholipase A2 (PLA2)) present in both haenbadr lower layer (HDL) and LDL contributes to the hydrolysis of oxPC molecules

Read more

Summary

Introduction

Lipoproteins modified by oxidation, including oxidized low-density lipoprotein (oxLDL) and oxidized high-density lipoprotein (oxHDL), are crucial for atherosclerosis development. At least two types of in vivo oxLDL were separated by anion-exchange column chromatography, one of which was negatively charged particles and increased by three-fold in the plasma obtained from patients with acute myocardial infarction compared to healthy plasma This in vivo oxLDL had unique characteristics; first, its apoB-100 was modified with oxidized products, including oxPC; second, it coeluted with oxHDL indicating that oxLDL could interact with oxHDL particles in this fraction; third, the binding of oxLDL and oxHDL was not covalent but electrostatic. Short chain-oxPC was capable of transferring between lipoproteins and was susceptible to hydrolysis by Lp-PLA2 These observations suggest that the oxPC and lysoPC species can be metabolized by interactions between oxLDL and HDL during the oxidation of LDL in vivo

Materials
Preparation of Human Lipoproteins
Preparation of 16:0 d13-lysoPC from 16:0-16:0 d13-PC
Preparation of d13-PGPC
LDL Labeling with 16:0 d13-lysoPC
LDL Labeling with d13-PGPC
Inhibition of Lp-PLA2 or LCAT Activity in HDL
Assessment of lysoPC Transfer and PC Generation
Assessment of LCAT Function
2.10. Assessment of PGPC Metabolism
2.12. Statistical Analysis
Transfer and Metabolism of d13-lysoPC
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call